- Home
- DRDB vs GEVO Comparison
DRDB vs GEVO Comparison
Compare DRDB & GEVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DRDB | GEVO |
|---|---|---|
| Founded | 2024 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Major Chemicals |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 319.5M | 470.1M |
| IPO Year | 2024 | 2011 |
Fundamental Metrics
Financial Performance| Metric | DRDB | GEVO |
|---|---|---|
| Price | $10.44 | $1.97 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.13 |
| AVG Volume (30 Days) | 18.7K | ★ 2.6M |
| Earning Date | 01-01-0001 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $120,932,000.00 |
| Revenue This Year | N/A | $913.54 |
| Revenue Next Year | N/A | $11.79 |
| P/E Ratio | $596.97 | ★ N/A |
| Revenue Growth | N/A | ★ 675.75 |
| 52 Week Low | $9.87 | $0.92 |
| 52 Week High | $10.47 | $2.98 |
Technical Indicators
Market Signals| Indicator | DRDB | GEVO |
|---|---|---|
| Relative Strength Index (RSI) | 52.39 | 38.60 |
| Support Level | $10.43 | $1.94 |
| Resistance Level | $10.45 | $2.24 |
| Average True Range (ATR) | 0.00 | 0.11 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 40.00 | 7.07 |
Price Performance
Historical ComparisonAbout DRDB Roman DBDR Acquisition Corp. II Ordinary shares
Roman DBDR Acquisition Corp II is a blank check company.
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.